CaMKII inhibition reduces isoproterenol-induced ischemia and arrhythmias in hypertrophic mice

Ying Feng; Jun Cheng; Baozhu Wei; Yanggan Wang

doi:10.18632/oncotarget.15099

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers: Pathology:

CaMKII inhibition reduces isoproterenol-induced ischemia and arrhythmias in hypertrophic mice

Ying Feng, Jun Cheng, Baozhu Wei and Yanggan Wang _

PDF | HTML | How to cite

Oncotarget. 2017; 8:17504-17509. https://doi.org/10.18632/oncotarget.15099

Metrics: PDF 2628 views | HTML 2825 views | ?

Abstract

Ying Feng1,*, Jun Cheng1,*, Baozhu Wei1 and Yanggan Wang1,2

1 Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, China

2 The Medical Research Institute of Wuhan University, Wuhan, China

* These authors have contributed equally to this work

Correspondence to:

Yanggan Wang, email:

Keywords: arrhythmia; CaMKII; cardiac hypertrophy; adrenergic stimulation; Pathology Section

Received: August 04, 2016 Accepted: January 23, 2017 Published: February 04, 2017

Abstract

Objectives: The Ca/calmodulin-dependent protein kinase II (CaMKII), an arrhythmogenic molecule, is excessively activated in cardiac hypertrophy. Here, we investigated the effect of CaMKII inhibition in isoproterenol (ISO)-induced arrhythmias in hypertrophic mice.

Results: ISO induced multiple types of arrhythmias in the hypertrophic mice but not in the normal mice. The QTc intervals were prolonged and the amplitudes of T waves were increased significantly by ISO prior to arrhythmia initiation. Inhibition of CaMKII prevented ISO-induced QTc prolongation and T wave elevation and abrogated arrhythmia induction.

Materials and Methods: Pressure-overload cardiac hypertrophy was induced in mice by thoracic aortic banding. Arrhythmias were recorded by electrocardiogram in conscious mice.

Conclusions: CaMKII inhibition is effective in suppressing adrenergic activation-induced ventricular arrhythmias in cardiac hypertrophy, of which the ventricular ischemia-induced CaMKII activation plays an important role.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 15099

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers: Pathology:

CaMKII inhibition reduces isoproterenol-induced ischemia and arrhythmias in hypertrophic mice

Abstract